Company logo Company name logo
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.     |     Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors.     |     KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |     ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Anlon Healthcare LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:544497NSE Symbol: AHCLP/E(TTM):35.49
ISIN Demat:INE0Y8W01025Div & Yield %:0EPS(TTM):0.55
Book Value(Rs):3.9466939Market Cap (rupee Cr.):1037.52Face Value(Rs):2
    
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 176.50120.2966.58112.8857.1415.98
Excise Duty0.000.000.000.000.000.00
Net Sales176.50120.2966.58112.8857.1415.98
Other Income 0.250.170.110.240.390.35
Stock Adjustments 16.92-3.3010.39-2.444.163.24
Total Income193.67117.1677.08110.6861.6919.57
EXPENDITURE :      
Raw Materials 129.7671.2944.0585.5147.4915.06
Power & Fuel Cost3.492.874.043.822.102.14
Employee Cost 5.254.884.363.682.783.08
Other Manufacturing Expenses 3.721.644.171.561.422.06
Selling and Administration Expenses 2.322.183.972.421.611.87
Miscellaneous Expenses 2.731.920.680.910.350.20
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure147.2784.7861.2797.8955.7424.41
Operating Profit46.3932.3815.8112.795.94-4.84
Interest 4.353.724.173.934.213.21
Gross Profit42.0428.6611.648.861.73-8.05
Depreciation1.361.771.891.871.841.86
Profit Before Tax40.6826.899.756.99-0.11-9.91
Tax11.406.540.011.010.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.47-0.170.080.160.000.33
Reported Net Profit27.8120.529.665.82-0.11-10.24
Extraordinary Items 0.000.000.000.000.00-0.02
Adjusted Net Profit27.8120.529.665.82-0.11-10.22
Adjst. below Net Profit 5.480.010.000.00-0.210.00
P & L Balance brought forward23.042.52-7.51-13.33-13.02-2.98
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.000.00
P & L Balance carried down56.3323.042.14-7.51-13.33-13.22
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr5.235.156.044.85-0.09-8.53
Earnings Per Share(Adj)-Unit Curr0.52NANANANANA
Book Value-Unit Curr39.4720.1813.146.151.301.39